Hope Biosciences LLC
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2016-04-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hope.bio
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)โข Click on a phase to view related trials
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
- Conditions
- Acute Kidney Injury
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- Hope Biosciences LLC
- Target Recruit Count
- 70
- Registration Number
- NCT06654193
- Locations
- ๐บ๐ธ
The University of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธUniversity of California, San Francisco, San Francisco, California, United States
๐บ๐ธThe University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, United States
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
- Conditions
- Traumatic Brain Injury
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- Hope Biosciences LLC
- Target Recruit Count
- 51
- Registration Number
- NCT05951777
- Locations
- ๐บ๐ธ
Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston, Texas, United States
๐บ๐ธThe University of Texas Health Science at San Antonio, San Antonio, Texas, United States
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- Hope Biosciences LLC
- Registration Number
- NCT04228666
- Locations
- ๐บ๐ธ
Clinical Trial Network, Houston, Texas, United States
Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- Hope Biosciences LLC
- Registration Number
- NCT04087889
- Locations
- ๐บ๐ธ
Hope Biosciences, Sugar Land, Texas, United States
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- Hope Biosciences LLC
- Target Recruit Count
- 24
- Registration Number
- NCT04063215
- Locations
- ๐บ๐ธ
Memorial Hermann Hospital-Clinical Research Unit (MMH-CRU), Houston, Texas, United States
- Prev
- 1
- 2
- Next